Cargando…

Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients

BACKGROUND: It is well known that human clear cell renal cell carcinoma (ccRCC) is a highly immunogenic and chemo-resistant tumor. Recently, emerging data suggest that the immune checkpoint blockade therapy is an important breakthrough in the treatment against ccRCC. HHLA2, a recently reported membe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Lujun, Zhu, Dawei, Feng, Jun, Zhou, You, Wang, Qi, Feng, Huijing, Zhang, Junping, Jiang, Jingting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469208/ https://www.ncbi.nlm.nih.gov/pubmed/31015801 http://dx.doi.org/10.1186/s12935-019-0813-2

Ejemplares similares

Decreased RIG-I expression is associated with poor prognosis and promotes cell invasion in human gastric cancer
por: Chen, Lujun, et al.
Publicado: (2018)

HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer
por: Xu, Guocai, et al.
Publicado: (2021)

Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma
por: Wang, Song, et al.
Publicado: (2021)

Over-Expression and Prognostic Significance of HHLA2, a New Immune Checkpoint Molecule, in Human Clear Cell Renal Cell Carcinoma
por: Zhang, Zhen, et al.
Publicado: (2020)

Expression of B7-H6 expression in human hepatocellular carcinoma and its clinical significance
por: Chen, Lujun, et al.
Publicado: (2018)

Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients
por: Deng, Haifeng, et al.
Publicado: (2019)

HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma
por: Zhou, Qiang-Hua, et al.
Publicado: (2020)

The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma
por: Zhu, Dawei, et al.
Publicado: (2022)

Correction: HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma
Publicado: (2020)

Epigenetic signature predicts overall survival clear cell renal cell carcinoma
por: Wang, Yejinpeng, et al.
Publicado: (2020)

HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma
por: Xu, Yituo, et al.
Publicado: (2021)

Down-regulation of BCL2L13 renders poor prognosis in clear cell and papillary renal cell carcinoma
por: Meng, Fei, et al.
Publicado: (2021)

Abnormal expression and prognostic significance of EPB41L1 in kidney renal clear cell carcinoma based on data mining
por: Liang, Taotao, et al.
Publicado: (2020)

High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity
por: Liu, Shouyong, et al.
Publicado: (2021)

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
por: Wang, Yi, et al.
Publicado: (2021)

Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma
por: Zhang, Zedan, et al.
Publicado: (2020)

Pseudogene HSPA7 is a poor prognostic biomarker in Kidney Renal Clear Cell Carcinoma (KIRC) and correlated with immune infiltrates
por: Ding, Chunjin, et al.
Publicado: (2021)

Construction and validation of a ferroptosis-related long noncoding RNA signature in clear cell renal cell carcinoma
por: Zhu, Zhenpeng, et al.
Publicado: (2022)

KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy
por: Li, Yang, et al.
Publicado: (2022)

Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
por: Xing, Xiao-Liang, et al.
Publicado: (2021)

LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
por: Yang, Chunxiu, et al.
Publicado: (2021)

Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population
por: Zhao, Qiang, et al.
Publicado: (2020)

Comprehensive analysis of pyroptosis regulators and tumor immune microenvironment in clear cell renal cell carcinoma
por: Zhang, Yan, et al.
Publicado: (2021)

Overexpression and Role of HHLA2, a Novel Immune Checkpoint, in Colorectal Cancer
por: Kula, Agnieszka, et al.
Publicado: (2023)

Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma
por: Zhu, Ziwen, et al.
Publicado: (2018)

Identification of biological targets of therapeutic intervention for clear cell renal cell carcinoma based on bioinformatics approach
por: Chen, Yongsheng, et al.
Publicado: (2016)

Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
por: Zhang, Jin, et al.
Publicado: (2020)

Association between copy-number alteration of +20q, −14q and −18p and cross-sensitivity to tyrosine kinase inhibitors in clear-cell renal cell carcinoma
por: Wang, Liang, et al.
Publicado: (2020)

RHBDF2 gene functions are correlated to facilitated renal clear cell carcinoma progression
por: Wang, Lei, et al.
Publicado: (2021)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment
por: Luo, Min, et al.
Publicado: (2021)

Establishment and characterization of clear cell renal cell carcinoma cell lines with different metastatic potential from Chinese patients
por: Tan, Xiaojie, et al.
Publicado: (2013)

SNORD63 and SNORD96A as the non-invasive diagnostic biomarkers for clear cell renal cell carcinoma
por: Shang, Xiaoling, et al.
Publicado: (2021)

Overexpression of COL5A1 promotes tumor progression and metastasis and correlates with poor survival of patients with clear cell renal cell carcinoma
por: Feng, Gang, et al.
Publicado: (2019)

Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2019)

Overexpression of IRF3 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Wu, Jun, et al.
Publicado: (2021)

Overexpression of SNHG12 regulates the viability and invasion of renal cell carcinoma cells through modulation of HIF1α
por: Chen, Qiguang, et al.
Publicado: (2019)

A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma
por: Jiang, Wen, et al.
Publicado: (2019)

Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma
por: Zhang, Xiaoqin, et al.
Publicado: (2021)

LncRNA-LET inhibits cell growth of clear cell renal cell carcinoma by regulating miR-373-3p
por: Ye, Zhuo, et al.
Publicado: (2019)

miR-129-5p inhibits clear cell renal cell carcinoma cell proliferation, migration and invasion by targeting SPN
por: Gao, Bin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pkb4ln7spou8du98l4hh4t3prv